1. Market Research
  2. > Healthcare
  3. > Medical Facility Market Trends
  4. > In Vitro Fertilization Market in Asia Pacific - Country Analysis by End Users (Clinics, Hospitals, Surgical Centers, Clinical Research Institutes, Banks) Number of Cycles, Revenue, Market Share, Growth, Trends, and Forecast Through 2020

The IVF market in Asia Pacific is characterized by the growth in standards of living, growing number of couples delaying parenthood due to professional commitments and trends towards financial stability. The Asia Pacific IVF market, valued at $1.3 billion in 2012, is estimated to reach $4.2 billion by 2020. Delayed pregnancy in women is one of the major driving factors of the IVF market, as the chances of conceiving lowers with age. The success rate of getting pregnant with IVF technique is higher in the age group of 35-39. Other driving factors of the IVF market are rise in infertility rate due to rise in stress levels, change in life style and fertility related diseases.Asia in particular is facing the challenge of aging population and lower work force replacement. These trends would impact the socio-economic development and progress. Many countries in Asia Pacific which are Japan, North and South Korea, China, Vietnam, Singapore and Thailand have fertility rates that are way below the replacement fertility levels. According to the East West center study, Japan, South Korea, Singapore and Taiwan Asia’s prosperous economies have the lowest birth rate worldwide.Taiwan has the lowest birth per women which is 0.91 (2010) when compared with South Korea (1.15), Japan (1.39) and Singapore (1.16). This trend is due to couples postponing parenthood, couples preferring few children or rather no children at all.Countries in Asia Pacific with such lower levels of fertility have initiated innovative assistance programs to promote parenthood and provide subsidies on fertility treatments such as IVF. In addition, lower treatment cost as compared to western countries has also proved to be encouraging for the artificial reproductive treatment (ART) industry in the region. With the advancing technologies, the success ratio for ART, especially IVF, has also grown in the region. Together these factors have not only provided the region to improve on its birth rates but have also added to the growth of the medical tourism industry in the region. A number of countries have gain popularity for medical tourism, of which Malaysia, Thailand, Singapore, and India are the most preferred countries.

KEY BENEFITS
In-depth analysis of the IVF market in 12 major country market with a cross sectional analysis of  end users segmentsQuantitative analysis of the current market and estimations through 2013-2020Assessment and ranking of the factors affecting the global market and impact analysis of the sameAnalysis of trends in various geographic segments that would help the companies to plan their strategies depending on the region

COVERAGE
For the purpose of better understanding of the market, the report has covered 12 country markets and has presented a cross sectional analysis of each country market for end user segments. Both revenue and number of IVF cycles performed at various end use segments is calculated based on various indicators, authentic secondary sources, government publications and primary research with leading IVF providers in each of the country. The qualitative analysis is carried out for each country market for major trends and market dynamics. The major countries covered in this study include:IndiaChinaJapanVietnamKoreaAustraliaNew ZealandThailandMalaysiaIndonesiaPhilippinesSingaporeEach of these country markets has been analyzed for following end user segments:HospitalsClinicsSurgical CentersResearch institutesBanksApart from that, profiles of major market player in each of the country have also been provided for better understanding of market strategy and competitive scenario.

Table Of Contents

In Vitro Fertilization Market in Asia Pacific - Country Analysis by End Users (Clinics, Hospitals, Surgical Centers, Clinical Research Institutes, Banks) Number of Cycles, Revenue, Market Share, Growth, Trends, and Forecast Through 2020
1. REPORT OUTLINEandnbsp; 1.1. Report Descriptionandnbsp; 1.2. Key Benefitsandnbsp; 1.3. Coverageandnbsp; 1.4. Research Methodologyandnbsp;andnbsp;andnbsp;andnbsp; 1.4.1. Secondary Researchandnbsp;andnbsp;andnbsp;andnbsp; 1.4.2. Primary Researchandnbsp;andnbsp;andnbsp;andnbsp; 1.4.3. Analyst Models2. EXECUTIVE SUMMARYandhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;.CHAPTER PRICE: $2993. ASIA PACIFIC IN VITRO FERTILIZATION (IVF) MARKET (REVENUE AND NUMBER OF CYCLES) andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;.CHAPTER PRICE: $1,499andnbsp; 3.1. Overviewandnbsp; 3.2. IVF Pricing Trends by Countryandnbsp; 3.3. IVF Cycles by Countryandnbsp; 3.4. Driversandnbsp; 3.5. Restraintsandnbsp; 3.6. Opportunitiesandnbsp; 3.7. Market by End Userandnbsp;andnbsp;andnbsp;andnbsp; 3.7.1. Fertility clinicsandnbsp;andnbsp;andnbsp;andnbsp; 3.7.2. Hospitalsandnbsp;andnbsp;andnbsp;andnbsp; 3.7.3. Surgical centersandnbsp;andnbsp;andnbsp;andnbsp; 3.7.4. Banksandnbsp;andnbsp;andnbsp;andnbsp; 3.7.5. Clinical research institutesandnbsp; 3.8. Profiles of Major Playersandnbsp;andnbsp;andnbsp;andnbsp; 3.8.1. Thermo Fisher Scientific Inc.andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.1.1. Company overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.1.2. Company snapshotandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.1.3. Financial overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.1.4. Market shareandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.1.5. Strategic moves and developmentsandnbsp;andnbsp;andnbsp;andnbsp; 3.8.2. EMD Serono, Inc.andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.2.1. Company overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.2.2. Company snapshotandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.2.3. Financial overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.2.4. Market shareandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.2.5. Strategic moves and developmentsandnbsp;andnbsp;andnbsp;andnbsp; 3.8.3. Sun Pharmaceuticalandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.3.1. Company overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.3.2. Company snapshotandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.3.3. Financial overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.3.4. Market shareandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.3.5. Strategic moves and developmentsandnbsp;andnbsp;andnbsp;andnbsp; 3.8.4. Cadila Healthcare Ltd.andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.4.1. Company overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.4.2. Company snapshotandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.4.3. Financial overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.4.4. Market shareandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.4.5. Strategic moves and developmentsandnbsp;andnbsp;andnbsp;andnbsp; 3.8.5. LG Life Sciences.andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.5.1. Company overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.5.2. Company snapshotandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.5.3. Financial overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.5.4. Market shareandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 3.8.5.5. Strategic moves and developments4. CHINA IVF MARKET (REVENUE AND NUMBER OF CYCLES)andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;.CHAPTER PRICE: $799andnbsp; 4.1. Number of Cycles by Hospitals/Clinicsandnbsp; 4.2. Market by End Userandnbsp;andnbsp;andnbsp;andnbsp; 4.2.1. Fertility clinicsandnbsp;andnbsp;andnbsp;andnbsp; 4.2.2. Hospitalsandnbsp;andnbsp;andnbsp;andnbsp; 4.2.3. Surgical centersandnbsp;andnbsp;andnbsp;andnbsp; 4.2.4. Banksandnbsp;andnbsp;andnbsp;andnbsp; 4.2.5. Clinical research institutesandnbsp; 4.3. Driversandnbsp; 4.4. Restraintsandnbsp; 4.5. Regulatory issues, legislations and authoritiesandnbsp; 4.6. Insurance reimbursement scenarioandnbsp; 4.7. Profiles of Major Players (Reproductive andamp; and genetic Hospital Citic-Xiangya, Shenyang Hospital, China, IVF Center China, Shandong Provincial Hospital, China, Centre for Reproductive Medicine China)andnbsp;andnbsp;andnbsp;andnbsp; 4.7.1. Company overviewandnbsp;andnbsp;andnbsp;andnbsp; 4.7.2. Company snapshotandnbsp;andnbsp;andnbsp;andnbsp; 4.7.3. Financial overviewandnbsp;andnbsp;andnbsp;andnbsp; 4.7.4. Market shareandnbsp;andnbsp;andnbsp;andnbsp; 4.7.5. Strategic moves and developments5. JAPAN IVF MARKET (REVENUE AND NUMBER OF CYCLES)andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;.CHAPTER PRICE: $699andnbsp; 5.1. Number of Cycles by Hospitals/Clinicsandnbsp; 5.2. Market by End Userandnbsp;andnbsp;andnbsp;andnbsp; 5.2.1. Fertility clinicsandnbsp;andnbsp;andnbsp;andnbsp; 5.2.2. Hospitalsandnbsp;andnbsp;andnbsp;andnbsp; 5.2.3. Surgical centersandnbsp;andnbsp;andnbsp;andnbsp; 5.2.4. Banksandnbsp;andnbsp;andnbsp;andnbsp; 5.2.5. Clinical research institutesandnbsp; 5.3. Driversandnbsp; 5.4. Restraintsandnbsp; 5.5. Regulatory issues, legislations and authoritiesandnbsp; 5.6. Insurance reimbursement scenarioandnbsp; 5.7. Profiles of Major Players (Hiroshima Hart Clinic, IVF Japan, The Advanced Reproductive Technological Instituteandnbsp;(ARMT), Yoshida Ladies Clinic Reproductive ART Center, Iwaki-Womenand#39;s Clinic)andnbsp;andnbsp;andnbsp;andnbsp; 5.7.1. Company overviewandnbsp;andnbsp;andnbsp;andnbsp; 5.7.2. Company snapshotandnbsp;andnbsp;andnbsp;andnbsp; 5.7.3. Financial overviewandnbsp;andnbsp;andnbsp;andnbsp; 5.7.4. Market shareandnbsp;andnbsp;andnbsp;andnbsp; 5.7.5. Strategic moves and developments6. KOREA IVF MARKET (REVENUE AND NUMBER OF CYCLES)andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;.CHAPTER PRICE: $799andnbsp; 6.1. Number of Cycles by Hospitals/Clinicsandnbsp; 6.2. Market by End Userandnbsp;andnbsp;andnbsp;andnbsp; 6.2.1. Fertility clinicsandnbsp;andnbsp;andnbsp;andnbsp; 6.2.2. Hospitalsandnbsp;andnbsp;andnbsp;andnbsp; 6.2.3. Surgical centersandnbsp;andnbsp;andnbsp;andnbsp; 6.2.4. Banksandnbsp;andnbsp;andnbsp;andnbsp; 6.2.5. Clinical research institutesandnbsp; 6.3. Regulatory issues, legislations and authoritiesandnbsp; 6.4. Insurance reimbursement scenarioandnbsp; 6.5. Profiles of Major Players (Maria Fertility Hospital, Cha General Hospital, Seoul National University Hospital IVFandnbsp;Center, Dongtan Cheil Womenand#39;s Clinic Ajou University)andnbsp;andnbsp;andnbsp;andnbsp; 6.5.1. Company overviewandnbsp;andnbsp;andnbsp;andnbsp; 6.5.2. Company snapshotandnbsp;andnbsp;andnbsp;andnbsp; 6.5.3. Financial overviewandnbsp;andnbsp;andnbsp;andnbsp; 6.5.4. Market shareandnbsp;andnbsp;andnbsp;andnbsp; 6.5.5. Strategic moves and developments7. INDIA IVF MARKET (REVENUE AND NUMBER OF CYCLES)andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;.CHAPTER PRICE: $799andnbsp; 7.1. Number of Cycles by Hospitals/Clinicsandnbsp; 7.2. Market by End Userandnbsp;andnbsp;andnbsp;andnbsp; 7.2.1. Fertility clinicsandnbsp;andnbsp;andnbsp;andnbsp; 7.2.2. Hospitalsandnbsp;andnbsp;andnbsp;andnbsp; 7.2.3. Surgical centersandnbsp;andnbsp;andnbsp;andnbsp; 7.2.4. Banksandnbsp;andnbsp;andnbsp;andnbsp; 7.2.5. Clinical research institutesandnbsp; 7.3. Regulatory issues, legislations and authoritiesandnbsp; 7.4. Insurance reimbursement scenarioandnbsp; 7.5. Profiles of Major Players (Bourn Hall Clinic, Southend Fertility and IVF Centre, Morpheus IVF Fertility Center,andnbsp;Bloom Fertility Center, Manipal Ankur, Cloudnine Fertility, Nova IVI Fertility)andnbsp;andnbsp;andnbsp;andnbsp; 7.5.1. Company overviewandnbsp;andnbsp;andnbsp;andnbsp; 7.5.2. Company snapshotandnbsp;andnbsp;andnbsp;andnbsp; 7.5.3. Financial overviewandnbsp;andnbsp;andnbsp;andnbsp; 7.5.4. Market shareandnbsp;andnbsp;andnbsp;andnbsp; 7.5.5. Strategic moves and developments8. AUSTRALIA IVF MARKET (REVENUE AND NUMBER OF CYCLES) andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;.CHAPTER PRICE: $699andnbsp; 8.1. Number of Cycles by Hospitals/Clinicsandnbsp; 8.2. Market by End Userandnbsp;andnbsp;andnbsp;andnbsp; 8.2.1. Fertility clinicsandnbsp;andnbsp;andnbsp;andnbsp; 8.2.2. Hospitalsandnbsp;andnbsp;andnbsp;andnbsp; 8.2.3. Surgical centersandnbsp;andnbsp;andnbsp;andnbsp; 8.2.4. Banksandnbsp;andnbsp;andnbsp;andnbsp; 8.2.5. Clinical research institutesandnbsp; 8.3. Regulatory issues, legislations and authoritiesandnbsp; 8.4. Insurance reimbursement scenarioandnbsp; 8.5. Profiles of Major Players (Virtus Health, Monash IVF, Genea Limited, City Fertility, Flindersfertility)andnbsp;andnbsp;andnbsp;andnbsp; 8.5.1. Company overviewandnbsp;andnbsp;andnbsp;andnbsp; 8.5.2. Company snapshotandnbsp;andnbsp;andnbsp;andnbsp; 8.5.3. Financial overviewandnbsp;andnbsp;andnbsp;andnbsp; 8.5.4. Market shareandnbsp;andnbsp;andnbsp;andnbsp; 8.5.5. Strategic moves and developments9. NEW ZEALAND IVF MARKET (REVENUE AND NUMBER OF CYCLES) andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;.CHAPTER PRICE: $699andnbsp; 9.1. Number of Cycles by Hospitals/Clinicsandnbsp; 9.2. Market by End Userandnbsp;andnbsp;andnbsp;andnbsp; 9.2.1. Fertility clinicsandnbsp;andnbsp;andnbsp;andnbsp; 9.2.2. Hospitalsandnbsp;andnbsp;andnbsp;andnbsp; 9.2.3. Surgical centersandnbsp;andnbsp;andnbsp;andnbsp; 9.2.4. Banksandnbsp;andnbsp;andnbsp;andnbsp; 9.2.5. Clinical research institutesandnbsp; 9.3. Regulatory issues, legislations and authoritiesandnbsp; 9.4. Insurance reimbursement scenarioandnbsp; 9.5. Profiles of Major Players (Fertility Associates New Zealand, Fertility Plus, Repromed)andnbsp;andnbsp;andnbsp;andnbsp; 9.5.1. Company overviewandnbsp;andnbsp;andnbsp;andnbsp; 9.5.2. Company snapshotandnbsp;andnbsp;andnbsp;andnbsp; 9.5.3. Financial overviewandnbsp;andnbsp;andnbsp;andnbsp; 9.5.4. Market shareandnbsp;andnbsp;andnbsp;andnbsp; 9.5.5. Strategic moves and developments10. SOUTH-EAST ASIA IVF MARKET (REVENUE AND NUMBER OF CYCLES) andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;.CHAPTER PRICE: $3,999andnbsp;andnbsp; 10.1. Number of Cycles by Hospitals/Clinicsandnbsp;andnbsp; 10.2. Market by End Userandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.2.1. Fertility clinicsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.2.2. Hospitalsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.2.3. Surgical centersandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.2.4. Banksandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.2.5. Clinical research institutesandnbsp;andnbsp; 10.3. Regulatory issues, legislations and authoritiesandnbsp;andnbsp; 10.4. Insurance reimbursement scenarioandnbsp;10.5. SINGAPORE IVF MARKET (REVENUE AND NUMBER OF CYCLES) andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;.CHAPTER PRICE: $799andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.5.1. Number of Cycles by Hospitals/Clinicsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.5.2. Market by End Userandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.5.2.1. Fertility clinicsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.5.2.2. Hospitalsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.5.2.3. Surgical centersandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.5.2.4. Banksandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.5.2.5. Clinical research institutesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.5.3. Regulatory issues, legislations and authoritiesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.5.4. Insurance reimbursement scenarioandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.5.5. Profiles of Major Players (NUH IVF Centre, Thomson Fertility Centre, Mount Elizabeth Fertility Center,andnbsp;Parkview Fertility Centre, Raffles Fertility Centre)andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.5.5.1. Company overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.5.5.2. Company snapshotandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.5.5.3. Financial overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.5.5.4. Market shareandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.5.5.5. Strategic moves and developmentsandnbsp;10.6. MALAYSIA IVF MARKET (REVENUE AND NUMBER OF CYCLES) andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;.CHAPTER PRICE: $799andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.6.1. Number of Cycles by Hospitals/Clinicsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.6.2. Market by End Userandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.6.2.1. Fertility clinicsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.6.2.2. Hospitalsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.6.2.3. Surgical centersandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.6.2.4. Banksandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.6.2.5. Clinical research institutesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.6.3. Regulatory issues, legislations and authoritiesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.6.4. Insurance reimbursement scenarioandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.6.5. Profiles of Major Players (Subang Fertility Center Subang Jaya Hospital, TMC Fertility Center formerlyandnbsp;known as Damansara Fertility center, Fertility Centre Scaudinavia, Concept Fertility Center (Malaysia), Medically Assistedandnbsp;Conception Centre)andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.6.5.1. Company overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.6.5.2. Company snapshotandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.6.5.3. Financial overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.6.5.4. Market shareandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.6.5.5. Strategic moves and developmentsandnbsp;10.7. INDONESIA IVF MARKET (REVENUE AND NUMBER OF CYCLES) andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;.CHAPTER PRICE: $799andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.7.1. Number of Cycles by Hospitals/Clinicsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.7.2. Market by End Userandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.7.2.1. Fertility clinicsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.7.2.2. Hospitalsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.7.2.3. Surgical centersandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.7.2.4. Banksandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.7.2.5. Clinical research institutesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.7.3. Regulatory issues, legislations and authoritiesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.7.4. Insurance reimbursement scenarioandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.7.5. Profiles of Major Players (Anugerah Fertility Center, Morula IVF, Fertility Centre, Siloam Hospitalsandnbsp;Surabana, Aster Fertility Clinic, Yasmin IVF)andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.7.5.1. Company overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.7.5.2. Company snapshotandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.7.5.3. Financial overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.7.5.4. Market shareandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.7.5.5. Strategic moves and developmentsandnbsp;10.8. PHILIPPINES IVF MARKET (REVENUE AND NUMBER OF CYCLES) andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;.CHAPTER PRICE: $799andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.8.1. Number of Cycles by Hospitals/Clinicsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.8.2. Market by End Userandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.8.2.1. Fertility clinicsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.8.2.2. Hospitalsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.8.2.3. Surgical centersandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.8.2.4. Banksandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.8.2.5. Clinical research institutesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.8.3. Regulatory issues, legislations and authoritiesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.8.4. Insurance reimbursement scenarioandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.8.5. Profiles of Major Players (Center for Reproductive Medicine, Victory Art Lab, CRM-MIA-Philippines)andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.8.5.1. Company overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.8.5.2. Company snapshotandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.8.5.3. Financial overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.8.5.4. Market shareandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.8.5.5. Strategic moves and developmentsandnbsp;10.9. THAILAND IVF MARKET (REVENUE AND NUMBER OF CYCLES) andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;.CHAPTER PRICE: $799andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.9.1. Number of Cycles by Hospitals/Clinicsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.9.2. Market by End Userandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.9.2.1. Fertility clinicsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.9.2.2. Hospitalsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.9.2.3. Surgical centersandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.9.2.4. Banksandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.9.2.5. Clinical research institutesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.9.3. Regulatory issues, legislations and authoritiesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.9.4. Insurance reimbursement scenarioandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.9.5. Profiles of Major Players (Bangkok Fertility Center, Jetanin Institute for Assisted Reproduction, Perfectandnbsp;Woman Institute Piyavate Hospital, Ramathibodi Hosp, Mahidol University, Bangkok Thailand, Siriraj Hospital)andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.9.5.1. Company overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.9.5.2. Company snapshotandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.9.5.3. Financial overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.9.5.4. Market shareandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.9.5.5. Strategic moves and developmentsandnbsp;10.10. VIETNAM IVF MARKET (REVENUE AND NUMBER OF CYCLES)andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;andhellip;.CHAPTER PRICE: $799andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.10.1. Number of Cycles by Hospitals/Clinicsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.10.2. Market by End Userandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.10.2.1. Fertility clinicsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.10.2.2. Hospitalsandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.10.2.3. Surgical centersandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.10.2.4. Banksandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.10.2.5. Clinical research institutesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.10.3. Regulatory issues, legislations and authoritiesandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.10.4. Insurance reimbursement scenarioandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.10.5. Profiles of Major Players (IVF Center of National Hospital of GB. Gyn, IVF Lab Tu Du Hospital Vietnam,andnbsp;IVF Van Hanh, IVFAS, Tu Du - Ho Chi Minh City Vietnam)andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.10.5.1. Company overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.10.5.2. Company snapshotandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.10.5.3. Financial overviewandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.10.5.4. Market shareandnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp;andnbsp; 10.10.5.5. Strategic moves and developmentsLIST OF TABLESTABLE 1andnbsp;andnbsp; andnbsp;ASIA PACIFIC IVF CYCLES BY COUNTRY, 2012 anddash; 2020 (THOUSAND)TABLE 2andnbsp;andnbsp; andnbsp;ASIA PACIFIC IVF REVENUE BY COUNTRY, 2012 anddash; 2020 ($MILLION)TABLE 3andnbsp;andnbsp; andnbsp;ASIA PACIFIC IVF CYCLES BY END USER, 2012 anddash; 2020 (THOUSAND)TABLE 4andnbsp;andnbsp; andnbsp;ASIA PACIFIC IVF REVENUE BY END USER, 2012 anddash; 2020 ($MILLION)TABLE 5andnbsp;andnbsp; andnbsp;THERMO FISHER SCIENTIFIC INCandnbsp; BUSINESS OVERVIEWTABLE 6andnbsp;andnbsp; andnbsp;COMPANY SNAPSHOTTABLE 7andnbsp;andnbsp; andnbsp;EMD SERONO INC BUSINESS OVERVIEWTABLE 8andnbsp;andnbsp; andnbsp;COMPANY SNAPSHOTTABLE 9andnbsp;andnbsp; andnbsp;SUN PHARMACEUTICAL BUSINESS OVERVIEWTABLE 10andnbsp; COMPANY SNAPSHOTTABLE 11andnbsp; CADILA HEALTH CARE BUSINESS OVERVIEWTABLE 12andnbsp; COMPANY SNAPSHOTTABLE 13andnbsp; LG LIFE SCIENCEandnbsp; BUSINESS OVERVIEWTABLE 14andnbsp; COMPANY SNAPSHOTTABLE 15andnbsp; CHINA IVF REVENUE BY END USERS, 2012 anddash; 2020 ($MILLION)TABLE 16andnbsp; CHINA IVF CYCLES BY END USERS, 2012 anddash; 2020 (THOUSAND)TABLE 17andnbsp; COOK MEDICAL INC BUSINESS OVERVIEWTABLE 18andnbsp; COMPANY SNAPSHOTTABLE 19andnbsp; VETROLIFE AB INC BUSINESS OVERVIEWTABLE 20andnbsp; COMPANY SNAPSHOTTABLE 21andnbsp; INDIA IVF REVENUE BY END USERS, 2012 anddash; 2020 ($MILLION)TABLE 22andnbsp; INDIA IVF CYCLES BY END USERS, 2012 anddash; 2020 (THOUSAND)TABLE 23andnbsp; SUN PHARMACEUTICAL BUSINESS OVERVIEWTABLE 24andnbsp; COMPANY SNAPSHOTTABLE 25andnbsp; TRIVECTOR ORIGIO SCIENTIFICandnbsp; BUSINESS OVERVIEWTABLE 26andnbsp; COMPANY SNAPSHOTTABLE 27andnbsp; LAB IVF ASIA BUSINESS OVERVIEWTABLE 28andnbsp; COMPANY SNAPSHOTTABLE 29andnbsp; LG LIFE SCIENCEandnbsp; BUSINESS OVERVIEWTABLE 30andnbsp; COMPANY SNAPSHOTTABLE 31andnbsp; CADILA HEALTH CAREandnbsp; BUSINESS OVERVIEWTABLE 32andnbsp; COMPANY SNAPSHOTTABLE 33andnbsp; KOREA IVF REVENUE BY END USERS, 2012 anddash; 2020 ($MILLION)TABLE 34andnbsp; KOREA IVF CYCLES BY END USERS, 2012 anddash; 2020 (THOUSAND)TABLE 35andnbsp; NEW ZEALAND IVF REVENUE BY END USERS, 2012 anddash; 2020 ($MILLION)TABLE 36andnbsp; NEW ZEALAND IVF CYCLES BY END USERS, 2012 anddash; 2020 (THOUSAND)TABLE 37andnbsp; AUSTRALIA IVF REVENUE BY END USERS, 2012 anddash; 2020 ($MILLION)TABLE 38andnbsp; AUSTRALIA IVF CYCLES BY END USERS, 2012 anddash; 2020 (THOUSAND)TABLE 39andnbsp; GENEA BIOMEDX TECHNOLOGIES BUSINESS OVERVIEWTABLE 40andnbsp; COMPANY SNAPSHOTTABLE 41andnbsp; THERMO FISHER SCIENTIFIC INCandnbsp; BUSINESS OVERVIEWTABLE 42andnbsp; COMPANY SNAPSHOTTABLE 43andnbsp; JAPAN IVF REVENUE BY END USERS, 2012 anddash; 2020 ($MILLION)TABLE 44andnbsp; JAPAN IVF CYCLES BY END USERS, 2012 anddash; 2020 (THOUSAND)TABLE 45andnbsp; EMD SERONO INC BUSINESS OVERVIEWTABLE 46andnbsp; COMPANY SNAPSHOTTABLE 47andnbsp; BIRTH RATE OF SOUTH-EAST ASIA PER THOUSAND, 2012TABLE 48andnbsp; SOUTH-EAST ASIA IVF REVENUE BY END USERS, 2012 anddash; 2013 ($MILLION)TABLE 49andnbsp; SOUTH-EAST ASIA IVF REVENUE BY COUNTRY, 2012 anddash; 2013 ($MILLION)TABLE 50andnbsp; SOUTH-EAST ASIA IVF CYCLES BY COUNTRY, 2012 anddash; 2013 (THOUSAND)TABLE 51andnbsp; SOUTH-EAST ASIA IVF CYCLES BY END USER, 2012 anddash; 2013 (THOUSAND)TABLE 52andnbsp; SINGAPORE IVF REVENUE BY END USERS, 2012 anddash; 2020 ($MILLION)TABLE 53andnbsp; SINGAPORE IVF CYCLES BY END USERS, 2012 anddash; 2020 (THOUSAND)TABLE 54andnbsp; PACIFIC HEALTHCAREandnbsp; BUSINESS OVERVIEWTABLE 55andnbsp; COMPANY SNAPSHOTTABLE 56andnbsp; ESCO TECHNOLOGIESandnbsp; BUSINESS OVERVIEWTABLE 57andnbsp; COMPANY SNAPSHOTTABLE 58andnbsp; EMD SERONO INC BUSINESS OVERVIEWTABLE 59andnbsp; COMPANY SNAPSHOTTABLE 60andnbsp; MALAYSIA IVF REVENUE BY END USERS, 2012 anddash; 2020 ($MILLION)TABLE 61andnbsp; MALAYSIA IVF CYCLES BY END USERS, 2012 anddash; 2020 (THOUSAND)TABLE 62andnbsp; INDONESIA IVF REVENUE BY END USERS, 2012 anddash; 2020 ($MILLION)TABLE 63andnbsp; INDONESIA IVF CYCLES BY END USERS, 2012 anddash; 2020 (THOUSAND)TABLE 64andnbsp; PHILIPPINES IVF REVENUE BY END USERS, 2012 anddash; 2020 ($MILLION)TABLE 65andnbsp; PHILIPPINES IVF CYCLES BY END USERS, 2012 anddash; 2020 (THOUSAND)TABLE 66andnbsp; THAILAND IVF REVENUE BY END USERS, 2012 anddash; 2020 ($MILLION)TABLE 67andnbsp; THAILAND IVF CYCLES BY END USERS, 2012 anddash; 2020 (THOUSAND)TABLE 68andnbsp; VIETNAM IVF REVENUE BY END USERS, 2012 anddash; 2020 ($MILLION)TABLE 69andnbsp; VIETNAM IVF CYCLES BY END USERS, 2012 anddash; 2020 (THOUSAND)LIST OF FIGURESFIG. 1andnbsp;andnbsp; ASIA PACIFIC IVF MARKET BY COUNTRY, 2013 andamp; 2020 ($MILLION)FIG. 2andnbsp;andnbsp; ASIA PACIFIC IVF MARKET BY END USERS, 2012 anddash; 2020 ($MILLION)FIG. 3andnbsp; PERCENTAGE OF PEOPLE WHO PERCEIVED VARIOUS INFERTILITY REASONS (SINGAPORE, THAILAND, INDONESIA AND CHINA)FIG. 4andnbsp;andnbsp; CHINA FERTILITY RATE (CHILDREN BORN/WOMEN)FIG. 5andnbsp;andnbsp; TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)FIG. 6andnbsp;andnbsp; TOTAL FERTILITY RATE (CHILDREN BORN/WOMEN) - SOUTH KOREAFIG. 7andnbsp;andnbsp; TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)FIG. 8andnbsp;andnbsp; TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)FIG. 9andnbsp;andnbsp; TOTAL FERTILITY RATE (CHILDREN BORN/ WOMEN)FIG. 10andnbsp; SINGAPORE FERTILITY RATE CHILD BORN/WOMENFIG. 11andnbsp; MALAYSIA FERTILITY RATE CHILD BORN/WOMENFIG. 12andnbsp; INDONESIA FERTILITY RATE CHILD BORN/WOMENFIG. 13andnbsp; PHILIPPINES FERTILITY RATE CHILD BORN/WOMENFIG. 14andnbsp; THAILAND FERTILITY RATE CHILD BORN/WOMENFIG. 15andnbsp; VIETNAM FERTILITY RATE CHILD BORN/WOMEN

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

Global Tumor Marker Diagnostic Testing Market: Future Horizons and Growth Strategies--Instrument and Reagents Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Opportunities

  • $ 21100
  • Industry report
  • August 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...

2016 Competing in the Global Cancer Diagnostics Market

2016 Competing in the Global Cancer Diagnostics Market

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

This new VPGMarketResearch.com comprehensive seven-country study identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next five years; examines trends ...

Tumor Markers 2020: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

Tumor Markers 2020: Reagents and Instrumentation--Supplier Shares and Strategies, Country Segment Forecasts, Emerging Opportunities

  • $ 21100
  • Industry report
  • October 2016
  • by Venture Planning Group

Complete report $34,750.  DataPack (test volumes, sales forecasts, supplier shares) $21,100. Highlights - Identifies and evaluates major business opportunities emerging in the tumor marker market during ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.